Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q2 2022 Earnings
ELVN
3
Aug
Expected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-2.24
-1.64
-1.03
-0.43
Details
Expected EPS
-0.4282
Actual EPS
-1.76
Surprise EPS
-1.33
Surprise Percent
+311.02%
Description
Enliven Therapeutics (ELVN) has reported earnings of -1.76 per share for Q2 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login